65.5 F
Los Angeles
Sunday, Nov 17, 2024
Log out
Subscribe
HomeHealth CareDrugs

Drugs

Health Care

Slew of New Drugs Sends Xencor Shares Soaring

Mark R. Madler -
Health Care

Atara Biotherapeutics Sees Its Stock Price Rise

Mark R. Madler -
Health Care

Arrowhead Teeing Up Drug Trials

Howard Fine -
Health Care

Atara Drug Gets Priority Review

Howard Fine -
Drugs

GoodRx Launches Price Tracker

Howard Fine -
Biosciences

Atara Shareholders Approve Reverse Stock Split

Mark R. Madler -
Drugs

Three Valley Bioscience Firms Reach FDA Milestones

Howard Fine -
Drugs

GoodRx Cuts New Deal with Kroger; Stock Sees Upgrades

Howard Fine -
Drugs

ImmunityBio Drug Gets FDA Nod

Howard Fine -
Drugs

Prolacta Starts Drug Development

Howard Fine -
Drugs

Arrowhead, Xencor Ink Licensing Deals Potentially Worth $1.5 Billion

Howard Fine -
Drugs

USC Testing New Ultrasound Tech for Breast Cancer Screening

staff-author -
Agribusiness

Pot Consultant Builds on Buzz

staff-author -
Doctors

Life Sciences Get Shot In Arm in L.A.

Garrett Reim -
Drugs

Pot Investors Try to Get Jump on Budding Market

Henry Meier -
Drugs

Cities Mull Means to Smoke Out Tax Revenue From Recreational Weed

Howard Fine -
Biotechnology

Immunotherapy Cancer Treatment Taking Flight

Hayley Fox -
Drugs

FDA Approves Biosimilar, Amgen’s Rival

Joel Russell -
Drugs

Health One to Stop Producing Unapproved Supplements and Drugs

Marni Usheroff -
Drugs

NantWorks Strikes Deal with Sorrento Therapeutics

Marni Usheroff -
Drugs

CytRx Plunges: FDA Halts Trials After Patient Death

Hannah Miet -
Drugs

Report: Amgen May Bid Less for Onyx

Deborah Crowe -
Drugs

FDA May Burn Smoking Business

Howard Fine -
Drugs

Herbalife’s Earnings Up But Guidance Down

Joel Russell -
Subscribe
Sign Up for Daily E-News Updates
Latest Articles

11150 Santa Monica Boulevard, Suite 350
Los Angeles, CA 90025
323-549-5225

Advertise with Us

About Us

Membership Center

Other Journals

© Los Angeles Business Journal